Previous close | 13.95 |
Open | N/A |
Bid | 12.20 |
Ask | 20.30 |
Strike | 245.00 |
Expiry date | 2024-06-28 |
Day's range | 13.95 - 13.95 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Is Eli Lilly stock a buy as it looks to enter the obstructive sleep apnea treatment market? Is LLY stock a buy right now?
The FDA grants priority review to Ionis' (IONS) filing seeking approval for olezarsen to treat adults with familial chylomicronemia syndrome. A final decision is expected in December 2024.
Investors need to pay close attention to Biogen (BIIB) stock based on the movements in the options market lately.